Results 121 to 130 of about 1,253,674 (265)
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang +3 more
wiley +1 more source
Overview of patient centric microsampling approach for monitoring respiratory biomarkers for treatment optimization. Image created in BioRender. Khan, A. (2026) https://BioRender.com/17jm5cs. ABSTRACT The clinical heterogeneity of respiratory disorders emphasizes the need for personalized approaches to prevention, diagnosis, and therapy.
Ahmar Khan +4 more
wiley +1 more source
Severe Recurrent COVID-Associated Pulmonary Aspergillosis: A Challenging Case
We report a rare case of severe COVID-19-associated pulmonary aspergillosis presenting as invasive pulmonary aspergillosis and subsequently invasive tracheobronchial aspergillosis during hospitalization in a critically ill patient who developed a further
Gian Anzellotti +13 more
core +1 more source
ABSTRACT Background Previous research indicated that physicians possess limited knowledge of the diagnosis and treatment of invasive fungal disease (IFD). Objective This study aimed to assess the efficacy of training via video or PDF formats in increasing physicians' knowledge of IFD.
Yijian Chen +18 more
wiley +1 more source
ABSTRACT Background Invasive pulmonary fungal infections (IPFIs) in immunocompromised children carry high morbidity and may interrupt life‐saving chemotherapy or haematopoietic stem cell transplantation (HSCT). Evidence on perioperative risk stratification for surgical management is limited.
Gang Yang +6 more
wiley +1 more source
Chronic pulmonary aspergillosis (CPA) is slowly progressive inflammatory pulmonary syndrome due to infection of Aspergillus spp. We conducted a randomized, multicenter, open-label trial comparing intravenous liposomal amphotericin B (L-AMB) of 2.5-5.0 mg/
Okimoto, Niro +9 more
core
Pathological Diagnosis of Pulmonary Aspergillosis
Pulmonary aspergillosis constitutes an increasingly prevalent and potentially fatal complex of mycotic diseases, caused by different species of Aspergillus.
Jensen, Henrik E., Becker, Cecilie B.
core +1 more source
Chronic necrotizing pulmonary aspergillosis in an immunocompetent, obese 10-year-old boy
Chronic necrotizing pulmonary aspergillosis is a rare form of pulmonary aspergillosis. It is usually seen in middle-aged or elderly patients with underlying chronic lung disease or mild immunodeficiency, and has been only rarely encountered in ...
Natasa Stojnic +4 more
doaj
Clinical Case of the Month. Pulmonary Aspergillosis: Chimic Necrotizing Aspergillosis [PDF]
peer reviewedPulmonary aspergillosis are uncommon diseases. The clinical expression of which are depending on the immunological status. The spectrum of pulmonary aspergillosis goes from hypersensitization to the invasive and disseminated aspergillosis ...
Golinval, Olivier, Louis, Renaud
core
Background We report a rare case of co-infection involving pulmonary tuberculosis and invasive aspergillosis following a liver transplant. Case presentation A 25-year-old female housewife immigrant from Afghanistan, who had autoimmune hepatitis and ...
Sara Abolghasemi +4 more
doaj +1 more source

